How is coronavirus affecting our operations? Learn more

Development and clinical progress of LRRK2 kinase inhibitors for the treatment of PD

Dr Esther Sammler (a consultant neurologist at Ninewells Hospital, Dundee) sent a reminder of the above talk by Ryan Watts, CEO of Denali Therapeutics. This will be a scientific talk,  but also likely of interest and relevance for People affected by Parkinson’s.

The event takes place on October 28th at 6pm (UK time) via Zoom.

Here is the registration link

Print this page
Back to top